Cynapept is a UAE-based pharmaceutical leader that unites Swiss precision engineering with cutting-edge American technology to deliver next-generation metabolic health solutions.
Our objective is clear: to become one of the world's most trusted innovators in obesity medicine — setting the benchmark for efficacy, safety, and patient outcomes across the globe.
UAE
Headquarters & Strategic Hub
3+
Premium Products Available
99.9%
Purity Guarantee Per Batch
GMP
Certified Manufacturing
To become one of the world's most trusted pharmaceutical innovators in metabolic health, setting the benchmark for efficacy and safety.
Scientific Innovation
Pushing the boundaries of metabolic medicine with cutting-edge research.
Premium Quality Standards
Rigorous quality controls and GMP certified production.
Global Manufacturing Excellence
Advanced facilities designed for scale and temperature-sensitive integrity.
Patient-Centric Approach
Delivering therapies optimized for compliance and premium patient experiences.
UAE Strategic Hub
Headquartered in the UAE — at the crossroads of global trade routes, providing unparalleled access to international markets.
Swiss Expertise
Precision engineering and pharmaceutical heritage from Swiss manufacturing standards applied to every product we produce.
American Technology
Cutting-edge US research and development — from advanced synthesis to state-of-the-art quality control systems.
GMP Quality Standards
Full adherence to international Good Manufacturing Practice standards, ensuring product safety and regulatory compliance.
Premium Approach
Modern pharmaceutical design focused on patient convenience, compliance, and optimal therapeutic outcomes.
Global Partnerships
An expansive and growing network of international medical partners, distributors, and research institutions.
Dubai, United Arab Emirates — expanding across the Middle East, Europe, and Asia.